Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Accounts Payables (2017 - 2021)

Historic Accounts Payables for Cogent Biosciences (COGT) over the last 5 years, with Q3 2021 value amounting to $4.3 million.

  • Cogent Biosciences' Accounts Payables rose 58059.47% to $4.3 million in Q3 2021 from the same period last year, while for Sep 2021 it was $4.3 million, marking a year-over-year increase of 58059.47%. This contributed to the annual value of $732000.0 for FY2020, which is 7700.28% down from last year.
  • As of Q3 2021, Cogent Biosciences' Accounts Payables stood at $4.3 million, which was up 58059.47% from $2.0 million recorded in Q2 2021.
  • Over the past 5 years, Cogent Biosciences' Accounts Payables peaked at $5.5 million during Q3 2018, and registered a low of $315000.0 during Q1 2021.
  • Its 5-year average for Accounts Payables is $2.0 million, with a median of $1.6 million in 2019.
  • As far as peak fluctuations go, Cogent Biosciences' Accounts Payables plummeted by 7700.28% in 2020, and later surged by 58059.47% in 2021.
  • Over the past 5 years, Cogent Biosciences' Accounts Payables (Quarter) stood at $1.3 million in 2017, then increased by 12.85% to $1.5 million in 2018, then surged by 109.55% to $3.2 million in 2019, then crashed by 77.0% to $732000.0 in 2020, then surged by 494.13% to $4.3 million in 2021.
  • Its Accounts Payables stands at $4.3 million for Q3 2021, versus $2.0 million for Q2 2021 and $315000.0 for Q1 2021.